Table 1.
General characteristics and treatment modalities of patients
| Total number of patients | 30 |
|---|---|
| Gender | |
| Female | 50% |
| Male | 50% |
| Stage | |
| Stage 1-b | 16.7% |
| Stage 2-a | 30% |
| Stage 3 | 53.3% |
| Histopathology | |
| Adenocarcinoma | 86.7% |
| Squamous cell carcinoma | 13.3% |
| CT regimen | |
| 5-FU | 20% |
| FUFA (5-FU, Folinic Acid) | 33.3% |
| Mac Donald | 16.7% |
| DCF (Docetaxel, 5-FU, Cisplatin) | 3.3% |
| Cisplatin | 26.5% |
| Mean RT dose | 46.5 Gy |
| Duration of follow-up | 3 months |
RT: Radiotherapy, CT: Chemotherapy, 5-FU: 5-Fluorouracil.